THE sales saga for Pfizer's consumer health business is rolling on, with US reports indicating Procter & Gamble has expressed interest in acquiring the operations.
A bidding process initiated by Pfizer last year has seen GSK, Reckitt Benckiser and Johnson & Johnson all exit from the auction, with Pfizer hoping to raise US$20b.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Apr 18
